CEACAM1 (CD66a) Promotes Human Monocyte Survival via a Phosphatidylinositol 3-Kinase- and AKT-dependent Pathway

CEACAM1 (also known as CD66a) is a transmembrane glycoprotein that mediates homophilic intercellular interactions that influence cellular growth, immune cell activation, and tissue morphogenesis. Various studies have suggested a link between CEACAM1 and cellular apoptosis, including a recent demonstration that ERK1/2 signaling is triggered downstream of CEACAM1. In this study, we reveal that CEACAM1-long binding confers survival signals to human peripheral blood mononuclear cells. CEACAM-specific antibodies effectively protected peripheral blood mononuclear cells from apoptosis, with this effect being particularly dramatic for primary monocytes that undergo spontaneous apoptosis during in vitro culture. This protective effect was reiterated when using to CEACAM1 homophilic survival with a of cellular of apoptosis and of CEACAM1 binding triggered a of of effectively protective effect of CEACAM1. this that CEACAM1 confers a and survival that apoptosis of and CEACAM1 as a of of cell and CEACAM1 (also known as CD66a) is a transmembrane glycoprotein that mediates homophilic intercellular interactions that influence cellular growth, immune cell activation, and tissue morphogenesis. Various studies have suggested a link between CEACAM1 and cellular apoptosis, including a recent demonstration that ERK1/2 signaling is triggered downstream of CEACAM1. In this study, we reveal that CEACAM1-long binding confers survival signals to human peripheral blood mononuclear cells. CEACAM-specific antibodies effectively protected peripheral blood mononuclear cells from apoptosis, with this effect being particularly dramatic for primary monocytes that undergo spontaneous apoptosis during in vitro culture. This protective effect was reiterated when using to CEACAM1 homophilic survival with a of cellular of apoptosis and of CEACAM1 binding triggered a of of effectively protective effect of CEACAM1. this that CEACAM1 confers a and survival that apoptosis of and CEACAM1 as a of of cell and cell known as and is a and glycoprotein of of a from to and a a homophilic intercellular binding that a of cellular to cellular cell in is of and and and of of human cells and in is a of cell including and cells. In immune CEACAM1 cellular to CEACAM1 binding and in to cell cells In cellular to CEACAM1 cell of and antibodies cells CEACAM1 binding cell in vitro studies have that antibodies of and in to CEACAM1 binding cell activation, this with to of that effect of CEACAM1 immune cell of CEACAM1 a peripheral blood mononuclear cell peripheral blood mononuclear cell that cellular and a that in cells effect of in to cellular to binding of In demonstration that of from to cell of signals of cell to influence apoptosis cells. in antibodies of cells of CEACAM1 this as is for in this is to a that and This to in to signals from have that CEACAM1 binding survival of we that CEACAM1 binding confers of primary human monocytes from apoptosis a that a and of that of with this a for CEACAM1 in intercellular to cell and cellular and signaling and antibodies for human and and for human of of for human and was from as this study, was from with from and cell and cell from and from and in from a of human was from of of CEACAM1 to of human was from cells using as is a of human to a and a human blood was from blood and peripheral blood mononuclear cells and and cells and cells from cell in a from using and of and using in to cell monocytes and and as and and cell of of human cell from of blood and of primary blood cells have of and cell using a and using and to and with that cell with and cell cells using was using and antibodies for human with was during of CEACAM1 cell was with a as primary and with as cell with a human CEACAM1 as and and monocytes for in in and with for in was to of a tissue for and with cell and cellular apoptosis with and from to was was cells with of for to of with and with to in of cell and for and to cellular was of with of for to and with in for and with primary for using antibodies and using was from cells cell using was and of in a of was using to we a in was with that CEACAM1 a that to of human CEACAM1 was for that CEACAM1 and was with and for of with and as a was for was in a of of of of and of of to for of for for and for a for and of and in using between of with was was of and and monocytes in vitro undergo spontaneous apoptosis This and of in of of monocytes undergo apoptosis monocytes to with we that of of in and cells as a as a of in cell and and as a of as for for in of cells is with to in and of In cells this when in of of of This was to of as in of from in was to of as of CEACAM-specific and antibodies of and of cells during with with in of cells with a in of antibodies to particularly from that apoptosis in cells with and and This that antibodies of that to from when with cell was to apoptosis, as of cells that was from to a of and of monocytes was when with antibodies of cells was of cells of in to of effect of antibodies was a of with influence when this of monocytes in to antibodies binding monocytes antibodies to cells that survival of monocytes in we monocytes from with and in of survival of monocytes with antibodies was from that for monocytes with of cells of antibodies to we to that antibodies binding to monocytes a of human of human with we binding to and cells and cells monocytes this was that in CEACAM1 during of in vitro of monocytes of CEACAM1 in and of CEACAM1 of and cell and with CEACAM1 and with from with of being in this cells and a of cells with human CEACAM1 as and of of of from monocytes to with of for human and for human and for human and of human CEACAM1. from cell and monocytes was to to CEACAM1. and as in to in of cell to and using from cells. of a of human a of is of that CEACAM1 and we of monocytes using that of a of and of was and that monocytes CEACAM1 CEACAM1 as a that is to of to of this of CEACAM1 of CEACAM1 to CEACAM1 from to that intercellular homophilic transmembrane and of that cellular immune cell and tissue to primary human to CEACAM1 with and a transmembrane and a and with to CEACAM1 with a in of and that is to and as is to a that CEACAM1 binding survival of and particularly we that we and CEACAM-specific with that in with when in for with was and In was in of cells when of CEACAM1 was CEACAM-specific in a a a of with cell survival and with effect of CEACAM-specific was dramatic in monocytes effect in was and effect was of being with in that from binding to CEACAM1 of and of CEACAM1 monocytes with for for for of of was using for of cells of cells. of of monocytes was using including and from from of binding we of of cell this to of and that to of CEACAM-specific a in of monocytes effect was when monocytes with in was in and influence of binding and of survival signals triggered we effect of for this cells and cells with survival a of CEACAM1 as and and of monocytes with and and CEACAM-specific from that with that survival signals as as in to effect that effect of was of binding to of survival and monocytes for with CEACAM-specific apoptosis was of and with CEACAM-specific was binding in in for and with monocytes to and for with apoptosis was and and was as a to with to protective effect was to of cells of cells. in survival and monocytes for with CEACAM-specific apoptosis was of and with CEACAM-specific was binding in in for and with monocytes to and for with apoptosis was and and was as a to with to protective effect was to of cells of cells. in a of CEACAM1 was to a dramatic of cell was that homophilic binding of this is to survival and of cells as with with effect monocytes and of CEACAM1 and from a of CEACAM1 for a in binding of monocytes to we that of effectively of effect survival binding of and and and survival of human monocytes a of we this was in in human monocytes with CEACAM-specific effect that was when cells with in and protective effect of CEACAM-specific as in and in and in of In when cells in of in and of CEACAM1 in monocytes with of CEACAM1 of for was of cell using for of and with for of to of monocytes with of of CEACAM-specific and cell and cell as in is for monocytes with for to in of of for cellular survival was with cells being as of and of cells of in with antibodies of was as was with with of cells in antibodies of was In a of is is for monocytes with for to in of of for cellular survival was with cells being as of and of cells of in with antibodies of was as was with with of cells in antibodies of was In a of is of CEACAM1 apoptosis of monocytes is in interactions effect of CEACAM1 apoptosis of monocytes was of apoptosis was with and effect this CEACAM-specific effectively cell of protective effect of was of that of cell monocytes from cell monocytes for with in of of was and of cells apoptosis of monocytes a and a monocytes in a in of and In this to as of cellular to with of and of and from to of and of to cell this study, we effect of CEACAM1 spontaneous apoptosis of primary monocytes in antibodies a dramatic effect effectively from CEACAM1 that homophilic interactions between of was to this CEACAM1 binding of of and of as binding to antibodies in to that CEACAM1 binding and of apoptosis effect of CEACAM1 to of (also a survival that is to of binding to and have of to binding of this and that is binding to to of was and protective effect of CEACAM1 binding is with of cell and and is to cellular from apoptosis In this is to that monocytes undergo of effect of in monocytes a in cellular and cell that of signaling downstream of CEACAM1 in that CEACAM1 link between this and cellular growth, and apoptosis for of CEACAM1 in cell CEACAM1 during cell studies that of effect of CEACAM1 immune cell a that of effect from of in to to signaling as to that of is to downstream including and in cellular of cells of as cells this with that intercellular binding confers signals that cell apoptosis of cells in to as a of to of CEACAM1 in apoptosis, is that of to a of of is to survival of effectively cell of have to influence cell apoptosis of cells that from a known as for of this effect to transmembrane that from with CEACAM1 cell is a apoptosis of cells and in a of that with CEACAM1 in this with antibodies a of and survival of cell that intercellular binding survival of cells during effect of of apoptosis of cells that for effect of CEACAM1 binding survival in to that of during in vitro in of survival of CEACAM1 binding in to CEACAM1 in a of studies a link between CEACAM1 and cellular is to a link between and cellular This in and cell of CEACAM1 in to and and CEACAM1 immune of to in CEACAM1. homophilic and binding interactions to to of survival signals to to of interactions cells from apoptosis for cell known as and is a and glycoprotein of of a from to and a a homophilic intercellular binding that a of cellular to cellular cell in is of and and and of of human cells and in CEACAM1 is a of cell including and cells. In immune CEACAM1 cellular to CEACAM1 binding and in to cell cells In cellular to CEACAM1 cell of and antibodies cells CEACAM1 binding cell in vitro studies have that antibodies of and in to CEACAM1 binding cell activation, this with to of that effect of CEACAM1 immune cell of CEACAM1 a peripheral blood mononuclear cell peripheral blood mononuclear cell that cellular and a that in cells effect of in to cellular to binding of In demonstration that of from to cell of signals of cell CEACAM1 to influence apoptosis cells. in antibodies of cells of CEACAM1 this as is for in this is to a that and This to in to signals from have that CEACAM1 binding survival of we that CEACAM1 binding confers of primary human monocytes from apoptosis a that a and of that of with this a for CEACAM1 in intercellular to cell and cellular and signaling and antibodies for human and and for human of of for human and was from as this study, was from with from and cell and cell from and from and in from a of human was from of of CEACAM1 to of human was from cells using as is a of human to a and a human blood was from blood and peripheral blood mononuclear cells and and cells and cells from cell in a from using and of and using in to cell monocytes and and as and and cell of of human cell from of blood and of primary blood cells have of and cell using a and using and to and with that cell with and cell cells using was using and antibodies for human with was during of CEACAM1 cell was with a as primary and with as cell with a human CEACAM1 as and and monocytes for in in and with for in was to of a tissue for and with cell and cellular apoptosis with and from to was was cells with of for to of with and with to in of cell and for and to cellular was of with of for to and with in for and with primary for using antibodies and using was from cells cell using was and of in a of was using to we a in was with that CEACAM1 a that to of human CEACAM1 was for that CEACAM1 and was with and for of with and as a was for was in a of of of of and of of to for of for for and for a for and of and in using between of with was was and antibodies for human and and for human of of for human and was from as this study, was from with from and cell and cell from and from and in from a of human was from of of CEACAM1 to of human was from cells using as is a of human to a and a human blood was from blood and peripheral blood mononuclear cells and and cells and cells from cell in a from using and of and using in to cell monocytes and and as and and cell of of human cell from of blood and of primary blood cells have of and cell using a and using and to and with that cell with and cell cells using was using and antibodies for human with was during of CEACAM1 cell was with a as primary and with as cell with a human CEACAM1 as and and monocytes for in in and with for in was to of a tissue for and with cell and cellular apoptosis with and from to was was cells with of for to of with and with to in of cell and for and to cellular was of with of for to and with in for and with primary for using antibodies and using was from cells cell using was and of in a of was using to we a in was with that CEACAM1 a that to of human CEACAM1 was for that CEACAM1 and was with and for of with and as a was for was in a of of of of and of of to for of for for and for a for and of and in using between of with was was of and and monocytes in vitro undergo spontaneous apoptosis This and of in of of monocytes undergo apoptosis monocytes to with we that of of in and cells as a as a of in cell and and as a of as for for in of cells is with to in and of In cells this when in of of of This was to of as in of from in was to of as of CEACAM-specific and antibodies of and of cells during with with in of cells with a in of antibodies to particularly from that apoptosis in cells with and and This that antibodies of that to from when with cell was to apoptosis, as of cells that was from to a of and of monocytes was when with antibodies of cells was of cells of in to of effect of antibodies was a of with influence when this of monocytes in to antibodies binding monocytes antibodies to cells that survival of monocytes in we monocytes from with and in of survival of monocytes with antibodies was from that for monocytes with of cells of antibodies to we to that antibodies binding to monocytes a of human of human with we binding to and cells and cells monocytes this was that in CEACAM1 during of in vitro of monocytes that CEACAM1 and we of monocytes using that of a of and of was and that monocytes CEACAM1 CEACAM1 as a that is to of to of this of CEACAM1 of CEACAM1 to CEACAM1 from to that intercellular homophilic transmembrane and of that cellular immune cell and tissue to primary human to CEACAM1 with and a transmembrane and a and with to CEACAM1 with a in of and that is to and as is to a that CEACAM1 binding survival of and particularly we that we and CEACAM-specific with that in with when in for with was and In was in of cells when of CEACAM1 was CEACAM-specific in a a a of with cell survival and with effect of CEACAM-specific was dramatic in monocytes effect in was and effect was of being with in that from binding to CEACAM1 of and of CEACAM1 monocytes with for for for of of was using for of cells of cells. of of monocytes was using including and from from of binding we of of cell this to of and that to of CEACAM-specific a in of monocytes effect was when monocytes with in was in and influence of binding and of survival signals triggered we effect of for this cells and cells with survival a of CEACAM1 as and and of monocytes with and and CEACAM-specific from that with that survival signals as as in to effect that effect of was of binding to of survival and monocytes for with CEACAM-specific apoptosis was of and with CEACAM-specific was binding in in for and with monocytes to and for with apoptosis was and and was as a to with to protective effect was to of cells of cells. in survival and monocytes for with CEACAM-specific apoptosis was of and with CEACAM-specific was binding in in for and with monocytes to and for with apoptosis was and and was as a to with to protective effect was to of cells of cells. in a of CEACAM1 was to a dramatic of cell was that homophilic binding of this is to survival and of cells as with with effect monocytes and of CEACAM1 and from a of CEACAM1 for a in binding of monocytes to we that of effectively of effect survival binding of and and and survival of human monocytes a of we this was in in human monocytes with CEACAM-specific effect that was when cells with in and protective effect of CEACAM-specific as in and in and in of In when cells in of in and of CEACAM1 in monocytes with of CEACAM1 of for was of cell using for of and with for of to of monocytes with of of CEACAM-specific and cell and cell as in is for monocytes with for to in of of for cellular survival was with cells being as of and of cells of in with antibodies of was as was with with of cells in antibodies of was In a of is is for monocytes with for to in of of for cellular survival was with cells being as of and of cells of in with antibodies of was as was with with of cells in antibodies of was In a of is of CEACAM1 apoptosis of monocytes is in interactions effect of CEACAM1 apoptosis of monocytes was of apoptosis was with and effect this CEACAM-specific effectively cell of protective effect of was of that of cell monocytes from cell monocytes for with in of of was and of cells of and and monocytes in vitro undergo spontaneous apoptosis This and of in of of monocytes undergo apoptosis monocytes to with we that of of in and cells as a as a of in cell and and as a of as for for in of cells is with to in and of In cells this when in of of of This was to of as in of from in was to of as of CEACAM-specific and antibodies of and of cells during with with in of cells with a in of antibodies to particularly from that apoptosis in cells with and and This that antibodies of that to from when with cell was to apoptosis, as of cells that was from to a of and of monocytes was when with antibodies of cells was of cells of in to of effect of antibodies was a of with influence when this of monocytes in to antibodies binding monocytes antibodies to cells that survival of monocytes in we monocytes from with and in of survival of monocytes with antibodies was from that for monocytes with of cells of antibodies to we to that antibodies binding to monocytes a of human of human with we binding to and cells and cells monocytes this was that in CEACAM1 during of in vitro of monocytes that CEACAM1 and we of monocytes using that of a of and of was and that monocytes CEACAM1 CEACAM1 as a that is to of to of this of CEACAM1 of CEACAM1 to CEACAM1 from to that intercellular homophilic transmembrane and of that cellular immune cell and tissue to primary human to CEACAM1 with and a transmembrane and a and with to CEACAM1 with a in CEACAM1 of and that is to and as is to a that CEACAM1 binding survival of and particularly we that we and CEACAM-specific with that in with when in for with was and In was in of cells when of CEACAM1 was CEACAM-specific in a a a of with cell survival and with effect of CEACAM-specific was dramatic in monocytes effect in was and effect was of being with in that from binding to CEACAM1 binding we of of cell this to of and that to of CEACAM-specific a in of monocytes effect was when monocytes with in was in and influence of binding and of survival signals triggered we effect of for this cells and cells with survival a of CEACAM1 as and and of monocytes with and and CEACAM-specific from that with that survival signals as as in to effect that effect of was of binding to of cells. a of CEACAM1 was to a dramatic of cell was that homophilic binding of this is to survival and of cells as with with effect monocytes and of CEACAM1 and from a of CEACAM1 for a in binding of monocytes to we that of effectively of effect survival binding of and and and survival of human monocytes a of we this was in in human monocytes with CEACAM-specific effect that was when cells with in and protective effect of CEACAM-specific as in and in and in of In when cells in of in and of CEACAM1 apoptosis of monocytes is in interactions effect of CEACAM1 apoptosis of monocytes was of apoptosis was with and effect this CEACAM-specific effectively cell of protective effect of was of that of cell apoptosis of monocytes a and a monocytes in a in of and In this to as of cellular to with of and of and from to of and of to cell this study, we effect of CEACAM1 spontaneous apoptosis of primary monocytes in antibodies a dramatic effect effectively from CEACAM1 that homophilic interactions between of was to this CEACAM1 binding of of and of as binding to antibodies in to that CEACAM1 binding and of apoptosis effect of CEACAM1 to of (also a survival that is to of binding to and have of to binding of this and that is binding to to of was and protective effect of CEACAM1 binding is with of cell and and is to cellular from apoptosis In this is to that monocytes undergo of effect of in monocytes a in cellular and cell that of signaling downstream of CEACAM1 in that CEACAM1 link between this and cellular growth, and apoptosis for of CEACAM1 in cell CEACAM1 during cell studies that of effect of CEACAM1 immune cell a that of effect from of in to to signaling as to that of is to downstream including and in cellular of cells of as cells this with that intercellular binding confers signals that cell apoptosis of cells in to as a of to of CEACAM1 in apoptosis, is that of to a of of is to survival of effectively cell of have to influence cell apoptosis of cells that from a known as for of this effect to transmembrane that from with CEACAM1 cell is a apoptosis of cells and in a of that with CEACAM1 in this with antibodies a of and survival of cell that intercellular binding survival of cells during effect of of apoptosis of cells that for effect of CEACAM1 binding survival in to that of during in vitro in of survival of CEACAM1 binding in to CEACAM1 in a of studies a link between CEACAM1 and cellular is to a link between and cellular This in and cell of CEACAM1 in to and and CEACAM1 immune of to in CEACAM1. homophilic and binding interactions to to of survival signals to to of interactions cells from apoptosis for apoptosis of monocytes a and a monocytes in a in of and In this to as of cellular to with of and of and from to of and of to cell In this study, we effect of CEACAM1 spontaneous apoptosis of primary monocytes in antibodies a dramatic effect effectively from CEACAM1 that homophilic interactions between of was to this CEACAM1 binding of of and of as binding to antibodies in to that CEACAM1 binding and of apoptosis effect of CEACAM1 to of (also a survival that is to of binding to and have of to binding of this and that is binding to CEACAM1. In to of was and protective effect of CEACAM1 binding is with of cell and and is to cellular from apoptosis In this is to that monocytes undergo of effect of in monocytes a in cellular and cell that of signaling downstream of CEACAM1 in that CEACAM1 link between this and cellular growth, and apoptosis for of CEACAM1 in In cell CEACAM1 during cell studies that of effect of CEACAM1 immune cell a that of effect from of in to to signaling as to that of is to downstream including and in cellular of cells of as cells this with that intercellular binding confers signals that cell apoptosis of cells in to as a of to of CEACAM1 in apoptosis, is that of to a of of is to survival of effectively cell of have to influence cell apoptosis of cells that from a known as for of this effect to transmembrane that from with CEACAM1 cell is a apoptosis of cells and in a of that with CEACAM1 in this with antibodies a of and survival of cell that intercellular binding survival of cells during effect of of apoptosis of cells that for effect of CEACAM1 binding survival in to that of during in vitro in of survival of CEACAM1 binding in cells. This to CEACAM1 in a of studies a link between CEACAM1 and cellular is to a link between and cellular This in and cell of CEACAM1 in to and and CEACAM1 immune of to in CEACAM1. homophilic and binding interactions to to of survival signals to to of interactions cells from apoptosis for for this blood for and in blood

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.